InsiderClue
Insiders · Profile

Tyree James L

Director at GENELUX · Director at Innoviva · Executive Vice President at Abbott Laboratories. Filing since 15 Feb 2007. CIK 0001324991

GNLX GENELUX Corp Director · 4 trades INVA Innoviva, Inc. Director · 2 trades ABT Abbott Laboratories Executive Vice President · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
GNLX GENELUX Corp
30 Dec 2024
Director
Sold at will
3,460
$8.51K
7.0%
GNLX GENELUX Corp
11 Sep 2024
Director
Sold on a plan
1,730
$4.50K
3.5%
GNLX GENELUX Corp
29 May 2024
Director
Bought
6,250
no price
181%
GNLX GENELUX Corp
13 Dec 2023
Director
Sold at will
9,000
$118.97K
72.2%
INVA Innoviva, Inc.
18 May 2016
Director
Sold, plan not stated
813
$8.51K
1.6%
INVA Innoviva, Inc.
2 Jun 2015
Director
Sold, plan not stated
2,438
$41.08K
6.8%
ABT Abbott Laboratories
27 Feb 2009
Executive Vice President
Sold, plan not stated
10,454
$498.46K
7.3%
ABT Abbott Laboratories
17 Feb 2009
Executive Vice President
Sold, plan not stated
5,565
$301.03K
5.1%
ABT Abbott Laboratories
2 Feb 2009
Executive Vice President
Sold, plan not stated
163,064
$8.94M
92.3%
ABT Abbott Laboratories
4 Mar 2008
Executive Vice President
Sold, plan not stated
10,096
$535.49K
7.9%
ABT Abbott Laboratories
3 Mar 2008
Executive Vice President
Sold, plan not stated
14,638
$778.89K
10.3%
ABT Abbott Laboratories
19 Feb 2008
Executive Vice President
Sold, plan not stated
884
$49.58K
0.6%
ABT Abbott Laboratories
1 Jun 2007
Senior Vice President
Sold, plan not stated
48,130
$2.73M
31.1%
ABT Abbott Laboratories
15 Feb 2007
Senior Vice President
Sold, plan not stated
1,500
$79.25K
1.7%
14 decisions on file.